Endovascular Today1d
Bentley’s BeGraft and BeFlared Gain TÜV Certification as Bridging Stents for FEVAR
Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...
Endovascular Today10d
Healionics’ Stargraft AV Dialysis Access Device Receives FDA Breakthrough Device Designation
Healionics Corporation announced that its Stargraft arteriovenous (AV) graft for dialysis access has been granted ...
Endovascular Today4d
Simcere’s Sanbexin Before Thrombectomy Studied to Improve Outcomes After AIS in TASTE-2
Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...
Endovascular Today10d
Arsenal Medical’s EMBO-02 Study of NeoCast Liquid Embolic for cSDH Begins in Australia
Arsenal Medical announced the initiation of the EMBO-02 clinical study of its NeoCast liquid embolic to treat chronic ...
Endovascular Today4d
1-Year Data Presented From enVVeno’s VenoValve Pivotal Trial
November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...
Endovascular Today3d
Solaris Endovascular, Inc. Launched in the United States
Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...
Endovascular Today4d
Xeltis Receives FDA Breakthrough Device Designation for aXess Vascular Access Conduit, Begins US Pivotal Trial
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...
Endovascular Today10d
R3 Vascular Receives IDE Approval for ELITE-BTK Pivotal Trial of Magnitude Scaffold
R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the compa ...
Endovascular Today10d
Humacyte’s ATEV Results Presented From V007 Phase 3 AV Access Trial
Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...
Endovascular Today20d
Resource Utilization and Outcomes With Penumbra’s CAVT in Intermediate-Risk PE Patients Compared to Other Treatment Modalities
November 4, 2024—A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with intermediate-risk pulmonary embolism (PE) treated with computer-assisted ...
Endovascular Today20d
Medtronic Presents Studies on Utility of Atherectomy to Treat PAD
November 4, 2024—Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. The first study, Total REALITY, retrospectively compared ...
Endovascular Today20d
Shockwave’s Javelin IVL Catheter Evaluated in Pooled Data From Mini S Feasibility and FORWARD PAD IDE Studies
November 4, 2024—The first clinical use of the Javelin peripheral intravascular lithotripsy (IVL) catheter (Shockwave Medical) for the treatment of peripheral artery disease (PAD) was evaluated in ...